Compact imaging system with single-photon sensitivity and picosecond time resolution for fluorescence-guided surgery with lifetime imaging capability

Author(s):  
F. Powolny ◽  
C. Bruschini ◽  
E. Dubikovskaya ◽  
E. Grigoriev ◽  
O. Michielin ◽  
...  
2014 ◽  
Author(s):  
F. Powolny ◽  
K. Homicsko ◽  
R. Sinisi ◽  
Claudio E. Bruschini ◽  
E. Grigoriev ◽  
...  

2020 ◽  
Vol 25 (05) ◽  
pp. 1
Author(s):  
Alberto J. Ruiz ◽  
Mindy Wu ◽  
Ethan Philip M. LaRochelle ◽  
Dimitris Gorpas ◽  
Vasilis Ntziachristos ◽  
...  

2014 ◽  
Vol 32 (15_suppl) ◽  
pp. e15219-e15219
Author(s):  
Yukihiko Hiroshima ◽  
Ali Maawy ◽  
Fuminari Uehara ◽  
Shinji Miwa ◽  
Shuya Yano ◽  
...  

2021 ◽  
pp. 1-9
Author(s):  
Lisa I. Wadiura ◽  
David Reichert ◽  
Veronika Sperl ◽  
Alexandra Lang ◽  
Barbara Kiesel ◽  
...  

OBJECTIVE Fluorescence-guided surgery using 5-aminolevulinic acid (5-ALA) is nowadays widely applied for improved resection of glioblastomas (GBMs). Initially, pretreatment with dexamethasone was considered to be essential for optimal fluorescence effect. However, recent studies reported comparably high rates of visible fluorescence in GBMs despite absence of dexamethasone pretreatment. Recently, the authors proposed fluorescence lifetime imaging (FLIM) for the quantitative analysis of 5-ALA–induced protoporphyrin IX (PpIX) accumulation. The aim of this study was thus to investigate the influence of dexamethasone on visible fluorescence and quantitative PpIX accumulation. METHODS The authors prospectively analyzed the presence of visible fluorescence during surgery in a cohort of patients with GBMs. In this study, patients received dexamethasone preoperatively only if clinically indicated. One representative tumor sample was collected from each GBM, and PpIX accumulation was analyzed ex vivo by FLIM. The visible fluorescence status and mean FLIM values were correlated with preoperative intake of dexamethasone. RESULTS In total, two subgroups with (n = 27) and without (n = 20) pretreatment with dexamethasone were analyzed. All patients showed visible fluorescence independent from preoperative dexamethasone intake. Furthermore, the authors did not find a statistically significant difference in the mean FLIM values between patients with and without dexamethasone pretreatment (p = 0.097). CONCLUSIONS In this first study to date, the authors found no significant influence of dexamethasone pretreatment on either visible 5-ALA fluorescence during GBM surgery or PpIX accumulation based on FLIM. According to these preliminary data, the authors recommend administering dexamethasone prior to fluorescence-guided surgery of GBMs only when clinically indicated.


2010 ◽  
Vol 18 (10) ◽  
pp. 10257 ◽  
Author(s):  
Day-Uei Li ◽  
Jochen Arlt ◽  
Justin Richardson ◽  
Richard Walker ◽  
Alex Buts ◽  
...  

2017 ◽  
Vol 8 (7) ◽  
pp. 3232 ◽  
Author(s):  
Davide Volpi ◽  
Iain D. C. Tullis ◽  
Paul R. Barber ◽  
Edyta M. Augustyniak ◽  
Sean C. Smart ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document